Developer of a precision exposome medicine platform designed to analyze the molecular impact of environmental exposures on health. The company offers a temporal exposome sequencing technology, enablin...

Healthcare
North Brunswick, NJ, United States
Founded 2020
39 employees
Website
Valuation
$0
Share Price
N/A
Total Raised
$34.6M
Last Round
N/A

Get the full picture

Create a free account to unlock LinusBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required